The aim of this study was to validate an automated immunoturbidimetric assay used to quantify human albumin in urine and to accurately measure canine albumin concentrations in both urine and cerebrospinal fluid. The partial homology existing between human and canine albumin limited the accuracy of the human assays in measuring canine albumin without method modifications. Thus, the assay was modified by calibrating the analyzer with calibrators made in the laboratory containing known concentrations of canine albumin. To prepare the set of calibrators, the albumin concentration of pooled sera of healthy dogs was assessed in 5 replicates using the BromocresolGreen assay. Pooled samples were aliquoted and serially diluted to obtain the expected concentrations of albumin (0.5, 1, 5, 13, and 30 mg/dl) for establishing the canine calibration curve. Thereafter, the performance was assessed by analyzing canine urine and CSF. The modified assay accurately quantified canine albumin in both specimens, as indicated by the following. Intra-and interassay variability was 0.92% and 2.74%, respectively; recovery was 99.66% and 99.07% in urine and 105.02% in CSF. No interference was detected when hemolysate and glucose were added to urine. The test was linear within the verified range (0-225 mg/dl). These results demonstrate that the modified human albumin immunoturbidimetric assay can be a useful tool in the veterinary diagnostic laboratory. It is accurate and tends itself to automatization on chemistry analyzers.
Measuring albumin concentrations in different biological specimens yields useful information to clinicians. High urinary albumin excretion may reflect glomerular damage, 10 whereas increased albumin concentration in cerebrospinal fluid (CSF) may permit the diagnosis of an alteration of blood-brain barrier integrity. 4 In humans, microalbuminuria and overt albuminuria are defined as urine albumin concentrations of 2-20 mg/dl and above 20 mg/dl, respectively. 9, 12, 15 Recent studies 15 validated an ELISA kit designed to measure canine albumin in different biological specimens and showed that pathological albuminuria commonly occurs in dogs, even if the normal range is not well established. Unfortunately, ELISA is time consuming and can hardly be carried out as a routine screening test. Furthermore, Pressler et al. 15 found that commercially available urine dipstick kits, used in human medicine to detect microalbuminuria in a semiquantitative manner, are not accurate and cannot be considered as reliable tools in the veterinary laboratory. An automated method for measuring canine albuminuria in a random sample would be particularly useful in evaluating glomerular damage in veterinary clinical From practice if it calculates the urine albumin to creatinine ratio. In fact, in humans, this ratio is strongly correlated with the albumin excretion during a 24-hour collection period, 1 which is reliable for humans but cumbersome for animals.
Immunological methods (both immunoturbidimetric and nephelometric) have been developed in human medicine to detect minimal amounts of albumin in specimens with low albumin concentration and are routinely used by clinical pathologists. Although albumin is well conserved among species and dog albumin (NCBI, Accession BAC10663) and human albumin (NCBI, Accession AAH39235) share a 79% homology in amino acid sequences, monoclonal antibodies against human albumin show only partial crossreactivity with canine albumin. This study is aimed at overcoming this cross-reactivity limitation by validating a human immunoturbidimetric assay (Microalbumin) a for accurately and routinely measuring canine albumin in both urine and CSF, using an automated analyzer. b All biological specimens (urine, CSF, and sera) were collected from dogs admitted to the University of Bologna Veterinary Teaching Hospital. To overcome the problem of partial cross-reactivity of goat anti-human albumin monoclonal antibodies against canine albumin, the automated analyzer was calibrated using known concentrations of canine analyte. Standard curves were prepared using canine sera collected and pooled from 10 healthy blood-donor dogs. In each case, serum albumin concentration was measured by 5 replicates using a BromocresolGreen (BCG) colorimetric assay, c and the mean was assumed to be the actual canine albumin concentration. Serial dilutions of sera were performed in a diluent composed of phosphate-buffered saline (PBS) (pH 7.4) supplemented with Triton X-100 d added in a rate of 2 ml/liter (PBS with Triton X-100 [PBST]). 2 Dilutions were calculated to obtain expected canine albumin concentrations of 0.50, 1, 5, 13, and 30 mg/dl. Ten standard curves with 5 points of calibration were prepared. Each point was assayed in duplicate. Coefficients of variation (CVs) of absorbances at each calibration point between standard curves were calculated. The automated analyzer was set at a linearity range between 0.5 and 30 mg/dl and with a 10-fold automated dilution when the albumin concentration exceeded the upper limits. All urine samples were included in this study regardless of the method of collection. Samples were immediately analyzed by dipstick, e and sediment examination was promptly performed. The remaining urine was centrifuged at 800 ϫ g for 10 minutes. Supernatant was assayed for the urinary protein to creatinine ratio (UTp/UCr), f,g within 2 hours after collection and stored at Ϫ30ЊC until assayed for albumin a concentration within 2 months from collection. For validating the test, canine urine samples were selected to cover the entire range of albuminuria, negligible albuminuria, microalbuminuria, and overt albuminuria, as defined in previous studies. 11, 15 Three samples of CSF with a broad range of total protein, assayed by a Red Pirogallol assay, f were included. A further selection criterion was the availability of a minimum of 2 ml of biological specimen.
For intraassay repeatability, the samples were assayed immediately after thawing at 37ЊC in a thermoblock. For interassay repeatability, the urine was frozen in separate vials at Ϫ30 C, thawed at 37 C, and assayed on 10 separate days during a period of 18 days. All analyses for both intraassay and interassay were performed in triplicate. Linearity was assessed using 2 canine urine samples with microalbuminuria (27 mg/dl) and overt albuminuria (225 mg/dl). Sam-ples were assayed undiluted and serially diluted using PBST to obtain 50%, 25%, 12.5%, 6.25%, 3.125%, 1.562%, and 0.78% of the analyte. Each measurement was carried out in duplicate and the mean calculated. Expected versus observed values were plotted in a linear regression analysis. To assess accuracy, a recovery method based on standard addition was used to evaluate the ability of the assay to recover the amount of analyte added to baseline samples of both urine and CSF. The baseline samples were obtained by the dilution of urine and CSF reference samples with PBST in equal amounts. 3 An interference experiment was performed by adding a solution containing hemoglobin-and glucose-interfering material (interferer) to 2 urine specimens with different albumin concentrations. These 2 specimens were negative for hemoglobin and glucose using the urinary test strip. To prepare the hemoglobin solution, canine blood erythrocytes were washed thrice using PBS, pH 7.4. Two hundred microliters of red blood cell pellet was lysed using 1 ml of hemolyzing reagent. h The hemolysate was centrifuged at 12,100 ϫ g for 2 minutes, and 0.5 ml of supernatant solution was harvested and assessed for hemoglobin i and albumin concentration. Standard solutions containing hemoglobin-interferer from 50 to 500 mg/dl were prepared. Standard glucose-interferers were obtained by dilution of a solution containing 36,300 mg/dl of glucose. An interference range from 250 to 3,000 mg/dl of glucose was evaluated. An equal amount of urine specimen and interferer were mixed and compared with the urine specimen to which an equal amount of distilled water was added. Measurements were performed in duplicate.
When canine and human standards with the same albumin concentration were compared using the unmodified assay, the absorbance values of the canine samples were lower than those of the corresponding human samples. Calibration curves, obtained with canine calibrators, were reproducible. The CVs of absorbances at each point calibration are shown in Table  1 . The polygonal calibration curve used in all the assays is shown in Fig. 1 . Intra-and interassay precision values were 0.92% and 2.74%, respectively ( Table 2) . Linear regression analysis yielded r values of 0.99992 and 0.99997 for samples containing 225 and 27 mg/ dl, respectively (Fig. 2) . The mean accuracy assessed by the recovery study was 99.07% and 99.66% for urine specimens and 105.02% for CSF samples (Table  3) . No interference by hemoglobin (up to 500 mg/dl added) and glucose (up to 3,000 mg/dl added) was detected. Previous studies 5, 7, 11 demonstrated that microalbuminuria is an early indicator of progressive renal disease in humans affected by diabetes mellitus and hypertension. Overt albuminuria is a hallmark of glomerular involvement in many autoimmune, neoplastic, and septic diseases. 6, 13, 16 Recent studies 8 showed that microalbuminuria (Ͼ1 mg/dl Ͻ30 mg/dl in 1010 SG normalized urine) is detectable in a large proportion (19%) of clinically healthy dogs. Conversely, hospitalized dogs showed 52% of patients affected by microalbuminuria or overt albuminuria. 14 Unfortunately, the standard urinary test strip gave many false-negative and false-positive results in detecting albuminuria. 17 We believe that an alternative tool other than a specific ELISA for measuring canine albumin, in a range varying from 1 to 200 mg/dl, is necessary for routine screening of urine in the clinical setting. The results of this study demonstrate that a modified human method for microalbuminuria detection is reliable for accurately and precisely measuring canine albumin concentrations in both urine and CSF. Moreover, the broad linearity range (from 0 to at least 225 mg/dl) appears even more useful by allowing detection of canine albumin in the range of microalbuminuria up to 
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